Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis

A dual role of B cells in experimental autoimmune encephalomyelitis (EAE), the animal model of the human autoimmune disease multiple sclerosis (MS), has been established. In the first role, B cells contribute to the pathogenesis of EAE through the production of anti-myelin antibodies that contribute to demyelination. On the contrary, B cells have also been shown to have protective functions in that they play an essential role in the spontaneous recovery from EAE. In this review, we summarize studies conducted in a number of species demonstrating the conditions under which B cells are pathogenic in EAE. We also discuss the phenotype and anti-inflammatory mechanisms of regulatory B cells.

[1]  A. Viola,et al.  Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion. , 2011, Blood.

[2]  N. Hellings,et al.  Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation , 2011, Journal of Neuroinflammation.

[3]  R. Flavell,et al.  Mice Lacking Endogenous IL-10–Producing Regulatory B Cells Develop Exacerbated Disease and Present with an Increased Frequency of Th1/Th17 but a Decrease in Regulatory T Cells , 2011, The Journal of Immunology.

[4]  A. Cross,et al.  Rituximab Therapy Reduces Organ-Specific T Cell Responses and Ameliorates Experimental Autoimmune Encephalomyelitis , 2011, PloS one.

[5]  Avijit Ray,et al.  A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis , 2011, Journal of Neuroimmunology.

[6]  P. Parren,et al.  Late B Cell Depletion with a Human Anti-Human CD20 IgG1κ Monoclonal Antibody Halts the Development of Experimental Autoimmune Encephalomyelitis in Marmosets , 2010, The Journal of Immunology.

[7]  D. Danilenko,et al.  B‐cell activation influences T‐cell polarization and outcome of anti‐CD20 B‐cell depletion in central nervous system autoimmunity , 2010, Annals of neurology.

[8]  T. Tedder,et al.  Regulatory B Cells (B10 Cells) and Regulatory T Cells Have Independent Roles in Controlling Experimental Autoimmune Encephalomyelitis Initiation and Late-Phase Immunopathogenesis , 2010, The Journal of Immunology.

[9]  M. Mostarica‐Stojković,et al.  Mechanisms of modulation of experimental autoimmune encephalomyelitis by chronic Trichinella spiralis infection in Dark Agouti rats , 2010, Parasite immunology.

[10]  R. Maizels,et al.  Helminth-induced CD 19 1 CD 23 hi B cells modulate experimental allergic and autoimmune inflammation , 2010 .

[11]  Moses Rodriguez,et al.  Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies. , 2009, Archives of neurology.

[12]  A. Waisman,et al.  Nonredundant Roles for B Cell-Derived IL-10 in Immune Counter-Regulation1 , 2009, The Journal of Immunology.

[13]  T. Tsubata,et al.  The Development and Function of Regulatory B Cells Expressing IL-10 (B10 Cells) Requires Antigen Receptor Diversity and TLR Signals1 , 2009, The Journal of Immunology.

[14]  K. Berer,et al.  Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells , 2009, The Journal of experimental medicine.

[15]  R. Geha,et al.  Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization. , 2009, The Journal of allergy and clinical immunology.

[16]  Carl-Fredrik Flach,et al.  B Lymphocytes Promote Expansion of Regulatory T Cells in Oral Tolerance: Powerful Induction by Antigen Coupled to Cholera Toxin B Subunit1 , 2008, The Journal of Immunology.

[17]  M. Fujimoto,et al.  Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. , 2008, The Journal of clinical investigation.

[18]  L. Qiao,et al.  Resting B cells expand a CD4+CD25+Foxp3+ Treg population via TGF‐β3 , 2008, European journal of immunology.

[19]  T. Lebien,et al.  B lymphocytes: how they develop and function. , 2008, Blood.

[20]  M. Fujimoto,et al.  A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. , 2008, Immunity.

[21]  U. Steinhoff,et al.  TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity1 , 2008, The Journal of Immunology.

[22]  D. Arnold,et al.  Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial , 2008, Annals of neurology.

[23]  D. Arnold,et al.  B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. , 2008, The New England journal of medicine.

[24]  A. Baxter,et al.  The origin and application of experimental autoimmune encephalomyelitis , 2007, Nature Reviews Immunology.

[25]  Wenda Gao,et al.  Reciprocal generation of Th1/Th17 and Treg cells by B1 and B2 B cells , 2007, European journal of immunology.

[26]  P. Jensen,et al.  Cutting Edge: Primary B Lymphocytes Preferentially Expand Allogeneic FoxP3+ CD4 T Cells , 2007, The Journal of Immunology.

[27]  S. Anderton,et al.  The Inflamed Central Nervous System Drives the Activation and Rapid Proliferation of Foxp3+ Regulatory T Cells1 , 2007, The Journal of Immunology.

[28]  S. Barnum,et al.  Complement in experimental autoimmune encephalomyelitis revisited: C3 is required for development of maximal disease. , 2007, Molecular immunology.

[29]  V. Kuchroo,et al.  Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation , 2007, Nature Medicine.

[30]  Yanping Tan,et al.  B Cell Regulation of CD4+CD25+ T Regulatory Cells and IL-10 Via B7 is Essential for Recovery From Experimental Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.

[31]  B. Becher,et al.  Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors , 2006, Proceedings of the National Academy of Sciences.

[32]  Loise M. Francisco,et al.  Blockade of CTLA-4 on CD4+CD25+ Regulatory T Cells Abrogates Their Function In Vivo1 , 2006, The Journal of Immunology.

[33]  M. Fujimoto,et al.  Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. , 2006, The American journal of pathology.

[34]  L. A. Stephens,et al.  Natural Recovery and Protection from Autoimmune Encephalomyelitis: Contribution of CD4+CD25+ Regulatory Cells within the Central Nervous System1 , 2005, The Journal of Immunology.

[35]  A. Rudensky,et al.  TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells , 2005, The Journal of experimental medicine.

[36]  Cheng-ming Sun,et al.  Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. , 2005, Immunity.

[37]  E. Frohman,et al.  Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis. , 2005, Archives of neurology.

[38]  S. Barnum,et al.  Deletion of the Complement Anaphylatoxin C3a Receptor Attenuates, Whereas Ectopic Expression of C3a in the Brain Exacerbates, Experimental Autoimmune Encephalomyelitis1 , 2004, The Journal of Immunology.

[39]  H. Rus,et al.  Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis. , 2003, The American journal of pathology.

[40]  N. Ruddle,et al.  Rat and Human Myelin Oligodendrocyte Glycoproteins Induce Experimental Autoimmune Encephalomyelitis by Different Mechanisms in C57BL/6 Mice1 , 2003, Journal of Immunology.

[41]  S. Miller,et al.  EncephalomyelitisExperimental Autoimmune System Inflammation During Active Immune Responses and Central Nervous Cells Suppress Antigen-Specific Autoreactive Regulatory T + CD25+ Cutting Edge: CD4 , 2022 .

[42]  David Gray,et al.  B cells regulate autoimmunity by provision of IL-10 , 2002, Nature Immunology.

[43]  T. Takai Roles of Fc receptors in autoimmunity , 2002, Nature Reviews Immunology.

[44]  Michael J. Ramsbottom,et al.  Critical role of antigen‐specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein , 2002, European journal of immunology.

[45]  B. Hall,et al.  Attenuation of Experimental Allergic Encephalomyelitis in Complement Component 6-Deficient Rats Is Associated with Reduced Complement C9 Deposition, P-Selectin Expression, and Cellular Infiltrate in Spinal Cords1 , 2002, The Journal of Immunology.

[46]  D. Pham‐Dinh,et al.  Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice , 2002, Journal of Neuroimmunology.

[47]  H. Lassmann,et al.  The Membrane Attack Complex of Complement Causes Severe Demyelination Associated with Acute Axonal Injury1 , 2002, The Journal of Immunology.

[48]  H. Lassmann,et al.  Fc Receptors are Critical for Autoimmune Inflammatory Damage to the Central Nervous System in Experimental Autoimmune Encephalomyelitis , 2002, Scandinavian journal of immunology.

[49]  M. Feldmann,et al.  Different Therapeutic Outcomes in Experimental Allergic Encephalomyelitis Dependant Upon the Mode of Delivery of IL-10: A Comparison of the Effects of Protein, Adenoviral or Retroviral IL-10 Delivery into the Central Nervous System1 , 2001, The Journal of Immunology.

[50]  E. Lavi,et al.  Cutting Edge: C3, a Key Component of Complement Activation, Is Not Required for the Development of Myelin Oligodendrocyte Glycoprotein Peptide-Induced Experimental Autoimmune Encephalomyelitis in Mice1 , 2001, The Journal of Immunology.

[51]  S. Swain,et al.  Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.

[52]  S. Barnum,et al.  Attenuation of Experimental Autoimmune Demyelination in Complement-Deficient Mice1 , 2000, The Journal of Immunology.

[53]  Shannon M. Anderson,et al.  Germinal Center Initiation, Variable Gene Region Hypermutation, and Mutant B Cell Selection without Detectable Immune Complexes on Follicular Dendritic Cells , 2000, The Journal of experimental medicine.

[54]  C. Janeway,et al.  Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice. , 2000, Journal of autoimmunity.

[55]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[56]  A. Cross,et al.  B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide , 1999, European journal of immunology.

[57]  S. Amor,et al.  The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages , 1999, Journal of Neuroimmunology.

[58]  R. Merchant,et al.  Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. , 1999, Journal of immunology.

[59]  R. Coffman,et al.  Transgenic Interleukin 10 Prevents Induction of Experimental Autoimmune Encephalomyelitis , 1999, The Journal of experimental medicine.

[60]  J. Fjell,et al.  B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. , 1998, Journal of immunology.

[61]  M. Fujimoto,et al.  CD19 regulates B lymphocyte responses to transmembrane signals. , 1998, Seminars in immunology.

[62]  H. Lassmann,et al.  B Lymphocytes Producing Demyelinating Autoantibodies: Development and Function in Gene-targeted Transgenic Mice , 1998, Journal of Neuroimmunology.

[63]  G. Stoll,et al.  Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system. , 1998, The American journal of pathology.

[64]  Charles A. Janeway,et al.  Experimental Autoimmune Encephalomyelitis Induction in Genetically B Cell–deficient Mice , 1996, The Journal of experimental medicine.

[65]  R. Schmidt,et al.  Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice , 1996 .

[66]  M. Ono,et al.  Augmented humoral and anaphylactic responses in FcγRII-deficient mice , 1996, Nature.

[67]  N. Letvin,et al.  Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. , 1995, The Journal of clinical investigation.

[68]  H. Lassmann,et al.  Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. , 1994, Journal of immunology.

[69]  K. Mohler,et al.  Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. , 1992, Journal of immunology.

[70]  D. Mason,et al.  Development and follicular localization of tolerant B lymphocytes in lysozyme/anti-lysozyme IgM/IgD transgenic mice. , 1992, International immunology.

[71]  H. Lassmann,et al.  The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement , 1991, Journal of Neuroimmunology.

[72]  Klaus Rajewsky,et al.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.

[73]  H. Lassmann,et al.  Antibody‐mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation , 1991, Clinical and experimental immunology.

[74]  J. Benjamins,et al.  Opsonization of normal myelin by anti-myelin antibodies and normal serum , 1989, Journal of Neuroimmunology.

[75]  H. Lassmann,et al.  Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. , 1988, The American journal of pathology.

[76]  H. Weiner,et al.  A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. , 1987, Journal of immunology.

[77]  H. Lassmann,et al.  Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG) , 1987, Journal of Neuroimmunology.

[78]  J. Trotter,et al.  Opsonization with Antimyelin Antibody Increases the Uptake and Intracellular Metabolism of Myelin in Inflammatory Macrophages , 1986, Journal of neurochemistry.

[79]  G. Danta,et al.  Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis , 1986, Journal of Neuroimmunology.

[80]  M. Webb,et al.  A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody , 1984, Journal of Neuroimmunology.

[81]  D. Willenborg,et al.  Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis , 1983, Journal of Neuroimmunology.

[82]  P. Y. Paterson TRANSFER OF ALLERGIC ENCEPHALOMYELITIS IN RATS BY MEANS OF LYMPH NODE CELLS , 1960, The Journal of experimental medicine.

[83]  J. Freund,et al.  The transfer of experimental allergic encephalomyelitis in the rat by means of parabiosis. , 1953, Journal of immunology.

[84]  P. K. Olitsky,et al.  EXPERIMENTAL DISSEMINATED ENCEPHALOMYELITIS IN WHITE MICE , 1949, The Journal of experimental medicine.

[85]  H. Lassmann,et al.  Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions , 2004, Acta Neuropathologica.

[86]  E. Reinke,et al.  Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. , 2003, International immunology.

[87]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[88]  H. Weiner,et al.  IL-4-Deficient and Transgenic Mice Demonstrated by Studies of IL-10- and Autoimmune Encephalomyelitis as IL-10 Is Critical in the Regulation of , 1998 .

[89]  R. Schmidt,et al.  Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. , 1996, Immunity.

[90]  M. Ono,et al.  Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. , 1996, Nature.

[91]  I. Cohen,et al.  The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis , 1981, European journal of immunology.